Article

How to promote and preserve eyelid health

Ocular Surface and Inflammation, Department Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain.
Clinical Ophthalmology (Impact Factor: 0.76). 10/2012; 6:1689-98. DOI: 10.2147/OPTH.S33133
Source: PubMed

ABSTRACT Disorders of the lacrimal functional unit are common in ophthalmological practice, with meibomian gland dysfunction, blepharitis, and dry eye forming a significant part of the general ophthalmologist's practice. The eyelid and its associated structures form a complex organ designed to protect the fragile corneal surface and improve visual acuity. This organ is subject to a number of disorders, including meibomian gland dysfunction, dry eye syndrome, anterior blepharitis, allergic and dermatological conditions, and disorders associated with contact lens use. Although commonly described separately, disorders of the lacrimal function unit are better considered as a group of interacting pathologies that have inflammatory mediators as a central feature. Eyelid hygiene, in the sense of routine cleansing and massage of the eyelids, is well accepted in the management of many disorders of the eyelid. However, a broader concept of eyelid health may be appropriate, in which eyelid cleansing is but a part of a more complete program of care that includes screening and risk assessment, patient education, and coaching. The ophthalmologist has an important role to play in helping patients persist with routine eyelid care that may be long-term or lifelong. A number of preparations exist to make routine eyelid care both more effective and more pleasant, and might also improve compliance. Several such preparations have been devised, and are being assessed in clinical studies, and appear to be effective and preferred by patients over traditional soap and water or baby shampoo.

0 Followers
 · 
96 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction L’hygiène des paupières incluant le massage et l’apport de chaleur par compresses chaudes, est un élément important de la prévention et du traitement des dysfonctions des glandes de Meibomius. Bien qu’efficace cette technique implique une participation active du patient et souffre de manque de standardisation. Blephasteam® est un dispositif médical ; les lunettes chauffantes, délivrent une chaleur humide constante sur les paupières afin de liquéfier le meibum et permettre un soulagement des symptômes et la prévention des rechutes. Matériel et méthodes L’étude ESPOIR (Évaluation de la satisfaction des patients vis-à-vis de la prise en charge des pathologies de surface oculaire) présentée, ici, avait pour objectif d’évaluer l’efficacité et la tolérance de ce dispositif médical chez les patients souffrant de dysfonctionnement des glandes de Meibomius (MGD). Un total de 28 centres français ont participé à l’étude. Cent deux patients présentant un dysfonctionnement symptomatique ou une sécheresse oculaire liée aux glandes de Meibomius ont été inclus. Les patients ont bénéficié de deux sessions quotidiennes de dispositif médical et ont recueilli sur un agenda personnel, un ensemble de paramètres, tous les deux jours la première semaine et ensuite de façon hebdomadaire pour les deux semaines restantes. Résultats La symptomatologie évaluée à l’aide d’une échelle visuelle analogique (EVA) par l’investigateur (critère principal) s’est montrée significativement (p < 0,001) améliorée en fin d’étude (59,97, 95 % CI 55,64–64,30 vs. 39,71, 95 % CI 34,78–44,65 à j0 et j21 respectivement), en parallèle avec le score moyen de symptômes (diminution moyenne de 19,93 ± 22,15 mm sur l’EVA ; p < 0,001), le score d’hyperémie (–1,57 ± 1,96 et –1,45 ± 1,85 ; p < 0,001 pour respectivement, l’œil le plus atteint et l’œil controlatéral), et la qualité du meibum (diminution moyenne de –4,03 ± 3,08 ; p < 0,001 et –3,32 ± 3,20 ; p < 0,01, pour respectivement, l’œil le plus atteint et l’œil controlatéral). Plus du double de patients ont rapporté que leurs symptômes s’étaient améliorés ou avaient disparu par rapport à ceux dont les symptômes étaient soit inchangés, soit aggravés. La symptomatologie globale évaluée par les patients a diminué tout au long de l’étude et une large majorité de patients ont été satisfaits ou très satisfaits du traitement. Avec les lunettes, la vision n’est pas réduite et le clignement des paupières est maintenu, ce qui favorise l’étalement du film lacrymal. Les patients ont pu continuer leurs activités quotidiennes comme la lecture ou le fait de regarder la télévision. Aucun effet indésirable n’a été rapporté et il n’y a pas eu de modifications de la pression intra-oculaire ou de l’acuité visuelle. La tolérance a été jugée satisfaisante ou très satisfaisante par plus de 95 % des investigateurs. Conclusion Cette étude suggère que le dispositif médical est efficace et bien toléré dans l’amélioration du confort oculaire et des symptômes liés aux MGD.
    Journal francais d'ophtalmologie 10/2014; 37(10). DOI:10.1016/j.jfo.2014.06.004 · 0.36 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Meibomian gland dysfunction (MGD) is widespread and has significant impact on patients' quality of life. Eyelid hygiene is the mainstay of treatment but is unstandardized and requires commitment from the patient and encouragement from the ophthalmologist. Blephasteam(®) is an eyelid warming device designed to be an easy-to-use and standardized treatment for MGD. In the present study, 73 patients were treated for 21 days with twice daily Blephasteam(®) sessions. The primary efficacy variable, a symptomatology visual analog scale score, declined from 63.07±21.23 (mean ± standard deviation) on day 0 to 41.90±25.49 on day 21. There were also improvements in a number of secondary efficacy variables including subjective ocular symptoms and clinical signs and symptoms of MGD and dry eye, though tear film breakup time and tear osmolarity were not improved. Global efficacy was assessed as satisfactory or very satisfactory in 83.8% of cases. Patient-reported subjective ocular symptoms declined during the study, and a majority of patients rated the efficacy of Blephasteam(®) as satisfactory or very satisfactory. Most patients found the device comfortable and were able to continue with normal activities (reading, watching TV, using a computer) during the Blephasteam(®) session. No safety or tolerability issues were identified.
    Clinical ophthalmology (Auckland, N.Z.) 10/2014; 8:2019-27. DOI:10.2147/OPTH.S68201
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this prospective study was to conduct histopathologic and lipidomic analyses of chalazia, in order to evaluate time-dependent changes in the lesion. Samples of surgically excised chalazia were collected over a period of 12 months from 10 patients (mean age 41 years; range, 23-58) with clinically diagnosed chalazia, who underwent scheduled surgery. The ages of chalazia varied from 2 to 28 weeks. To confirm the clinical diagnoses, the morphology of collected tissue samples was evaluated histologically after hematoxylin and eosin staining. The lipids from individual chalazia were analyzed by high-performance liquid chromatography-mass spectrometry and compared with authentic lipid standards and with the lipids of meibum collected from normal controls. We observed gradual, lesion age-dependent transformation of the lipidome of chalazia from an almost normal meibum-like composition to a very different kind of lipidome. A rapid initial increase in the free cholesterol content was followed by a gradual replacement of extremely long chain meibomian-type lipids with a mixture of shorter-chain cholesteryl esters of the C14-C18 family, triacylglycerols, ceramides, phospholipids and sphingomyelins. In addition, a rapid disappearance of wax esters and cholesteryl esters of (1-O)-acyl-omega-hydroxy fatty acids from the lipidome of aging chalazia was observed. Our results are indicative of dramatic, time-dependent changes in the lesion that may involve cholesterol as a trigger and/or a marker of subsequent degeneration of the meibomian lipidome. We hypothesize that early inhibition of these transformations may be useful in reversing the course of the disease.
    Experimental Eye Research 08/2014; 127. DOI:10.1016/j.exer.2014.08.008 · 3.02 Impact Factor

Preview

Download
6 Downloads
Available from